• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to novel compounds of formula(1). wherein: R1 is hydrogen atom or lower alkyl group, X is bromine atom or chlorine atom; and which are usefull for the preparation of the cycloheptanoides such as cycloheptimidazole derivatives. The compound having formula (1) is obtained in a single pot by the reaction of a trialkylsilylether compound with a dihalocarbene which, in turn, is prepared from the reaction of chloroform or bromoform in the presence of base.
    公开号:US20010008944A1
    申请号:US09/805,516
    申请日:2001-03-14
    公开日:2001-07-19
    发明作者:Tsuyoshi Tomiyama；Akira Tomiyama；Naoto Ueyama；Akira Ohno
    申请人:Tsuyoshi Tomiyama；Akira Tomiyama；Naoto Ueyama；Akira Ohno；
    IPC主号:C07D235-02
    专利说明:
    [0001] 1. Field of the Invention [0001]
    [0002] This invention relates to novel key intermediates, 3-hydoxy-2-halocycloheptenones and 3-alkoxy-2-halocycloheptenones, which are useful for the synthesis of drug medicine. In detail, this invention relates to preparation of the key intermediates of novel cycloheptimidazole derivatives that have angiotensin II receptor antagonistic activities and are therefore useful for the treatment of hypertension, congestive heart failure and so on. [0002]
    [0003] 2. Description of the Prior Art [0003]
    [0004] Many compounds containing cyclohept rings possess potent physiological activities. For example, we proposed cycloheptimidazoles of general formula (6) that have angiotensin II receptor antagonistic activities and are therefore useful for the treatment of hypertension or congestive heart failure. (Japanese Patent laid-open Publication 5-320139, 7-149761and 8-73454.) [0004]
    [0005] (wherein: R[0005] 5 is hydrogen atom or lower alkyl group, R6 is carboxyl group, tetrazolyl group) However, the synthetic method of the cycloheptaimidazoles, shown in general formula (6), is unfavorable on an industrial scale because of the following reasons.
    [0006] 1) The starting material, tropolone is expensive. [0006]
    [0007] 2) A large number of process steps are needed. [0007]
    [0008] 3) This procedure is not applicable to a wide range of cycloheptanoid compounds. [0008]
    [0009] Judging from the application of known method, it is a common concept that 1,3-cycloheptadione (8), prepared from the compound (2), is halogenated at the 2 position of compound (8) to obtain the general formula (1) containing compound (3) and (4). [0009]
    [0010] (wherein: R[0010] 2 and R3 is lower alkyl group, X is bromine atom or chlorine atom.) In other words Cyclohepta-1,3-dione (8) can be obtained by known method. First, cyclopropanation of compound (2) in the presence of Et2 Zn and CH2I2 (Simmons-Smith reaction) gives the bicyclic compound (7) (L. Hadjiarapoglou, Synthesis, 525, 1996). Second, ring enlargement of (7) using FeCl3 or periodic acid gives the compound (8) (T. Saegusa, Organic Synthesis 59, 113; M. C. Pirrung, J. Org. Chem. 52, 3606, 1987). Then the halo analogue (3) seems to be prepared in a similar manner as described by R. G. Shepherd (J.Chem. Soc. Perkin Trans. I, 2153,1987), and its etherification affords 2-halo-3-alkoxycyclohept-2-enone(4). However, Simmons-Smith reaction is not useful industrially because of following reasons.
    [0011] 1) The reaction condition is anhydrous. 2) Et[0011] 2Zn is subject to autoignition. Moreover, the objective compound (3) is not obtained under several conditions for halogenation of the compound (8), and dihalogenation reaction occurs and 2,2-dihalo-1,3-cycloheptandione (9) is obtained as a main product.
    [0012] Similarly, well-known procedure was not applicable to the synthesis of the compounds (3) and (4). Furthermore, although the compounds (10) (Chem. Abstr. 77, 48038k, 1972 (U.S. Pat. No. 3,658,841)), (11) and (12) (Chem. Abstr. 89, 179583e, 1978 (J. Org. Chem. 43, 4241, 1978)) have already been known, 3-hydroxy-2-halocycloheptenone and 3-alkoxy-2-halocycloheptenone, which are shown as general formula (1), below, are not yet reported and are new compounds. [0012]
    [0013] Problems to be Solved by the Invention [0013]
    [0014] This invention relates to novel key intermediates, useful for the preparation of the cycloheptanoides such as cycloheptimidazole derivatives which are useful for the synthesis of medicine and presents its use for the preparation of the cycloheptimidazoles. [0014] SUMMARY OF THE INVENTION
    [0015] We have explored to find a practical procedure, of wide range usefulness, for cycloheptanoide compounds. Consequently, we found that 3-hydroxy-2-halocycloheptenone and 3-alkoxy-2-halocycloheptenone were the most suitable intermediates and, at the same time, we found the practical synthetic procedure of these intermediates which is scalable for the industrial scale, and this invention was completed. [0015]
    [0016] Namely, the compounds of the present invention are compounds of general formula (1): [0016]
    [0017] wherein: R[0017] 1 is hydrogen atom or lower alkyl group, X is bromine atom or chlorine atom. In this invention, “lower” means straight or branched chain from C1 or C5. DETAILED DESCRIPTION OF THE INVENTION
    [0018] The compounds of general (1) such as 3-hydroxy-2-halocycloheptenone and 3-alkoxy-2-halocycloheptenone can be obtained from 1 ,2-bis(trialkylsilyloxy)cyclohexene (2) which is easily available in a few steps. The synthetic method for preparation of these compounds is shown as follows. [0018]
    [0019] wherein: R[0019] 2 and R3 are lower alkyl group, X is bromine atom or chlorine atom. Namely, the compound (13) is obtained by the reaction of 1,2-bis(trialkylsilyloxy)cyclohexene (2) with dihalocarbene which is prepared from chloroform or bromoform in the presence of base such as potassium tert-butoxide. Thus, two reactions, namely a ring chlorination and expansion, proceed in one pot and the compound (13) is subjected to ring expansion to obtain the compound (3) without isolation. This reaction is carried out in an inert organic solvent, such as, heptane, hexane and pentane, at from −40° C. to room temperature.
    [0020] Above mentioned compound (3) is reacted with alcohol such as methyl alcohol or ethyl alcohol in the presence of acid catalyst to give 3-alkoxy-2-chlorocycloheptenone (compound (4)) or 3-alkoxy-2-bromocycloheptenone. Hydrochloric acid, sulfonic acid, methanesulfonic acid, p-methylbenzene sulfonic acid and ion exchange resin can be used as an acid catalyst. This alkylation is also carried out in the presence of orthoester such as trimethyl orthoformate. In general, this reaction is carried out at a temperature of from 0° C. to room temperature. 1,2-Bis(trialkylsilyloxy) cyclohexene (2) can be prepared according to the reported methods (K. Rublmann., Synthesis, 236, 1971). [0020]
    [0021] Compounds of general formula (4) are as follows: 3-Methoxy-2-chlorocycloheptenone, 3-Methoxy-2-bromocycloheptenone, 3-Ethoxy-2-chlorocyclo-heptenone, 3-Ethoxy-2-bromocycloheptenone and so on. [0021]
    [0022] A compound of general formula (1) can be converted to various cycloheptanoide derivatives. For example, the compounds of general formula (5) are obtained by the reaction of compound (1) with alkylamidine hydrochloride in the presence of base. The compounds of general formula (5) are useful for the synthesis of cycloheptimidazole derivatives which have angiotensin II receptor antagonistic activities. [0022]
    [0023] wherein: R[0023] 1 is hydrogen atom or lower alkyl group, X is bromine atom or chlorine atom, R4 is lower alkyl group.
    [0024] For example, the compound (1) wherein R[0024] 1 is lower alkyl group is reacted with butylamidine hydrochloride in the presence of K2CO3 to give cycloheptimidazole derivatives (5) in which R4 is n-propyl group. In this reaction, 1,4-dioxane or chloroform-H2O are preferred as solvent. In general, this reaction is carried out at room temperature or under heating conditions. EXAMPLE Example 1 2-Chloro-3-hydroxycyclohept-1-one
    [0025] To a stirred mixture of 67.6 g of 1,2-bis(trimethylsilyloxy)cyclohex-1-ene and 52.1 g of potassium tert-butoxide in 600 mL of pentane, 25.1 mL of chloroform was added over 0.5 h at −20° C. After an additional 0.5 h at room temperature, 10 mL of 10% hydrochloric acid and 30 mL of water was added. After an additional 1 h at room temperature, the mixture was poured into 200 mL of saturated aqueous NaHCO[0025] 3. The aqueous layer was washed with two portions of ethyl acetate and adjusted to pH 3 using 5% hydrochloric acid solution, followed by extraction with chloroform. The organic solution was washed with brine and dried over Na2SO4, filtered and the solvent was evaporated in vacuo, to give 22 g of the title compound.
    [0026] MS(m/z): 162 (M[0026] +2), 160 (M+), 97, 84, 76, 55.
    [0027] [0027] 1H-NMR(CDCl3) δ: 1.97-2.00 (4H, m), 2.37-2.60 (4H, m), 3.60 (2H, s). Example 2 2-Chloro-3 -methoxycyclohept-1-one
    [0028] A mixture of 5.0 g of 2-chloro-3-hydroxycyclohept-1-one, 5.0 mL oftrimethyl orthoformate, and 30 mL of methanol was stirred in the presence of IR 120H ion-exchange resin (0.5 g, pre-washed with methanol) at room temperature. After 3 h the mixture was filtered and filtrate was extracted with ethyl acetate. The organic solution was washed with saturated aqueous NaHCO[0028] 3, brine and dried over Na2SO4, filtered and the solvent was evaporated in vacuo, to give 2.8 g of the title compound.
    [0029] MS(m/e): 176 (M[0029] +2), 174 (M+), 145, 118,97, 61
    [0030] IR cm[0030] −1(KBr): 2932, 1653, 1578, 1248, 1224.
    [0031] [0031] 1H-NMR(CD3OD) δ: 1.86 (4H, m), 2.19 (4H, q, J=5.3 Hz), 2.76 (2H, q, J=5.3Hz), 3.94 (3H, s). Example 3 2-Propyl-4,5,6,7-tetrahydrocycloheptimidazole-8-one
    [0032] A solution of 3.79 of butylamidine hydrochloride and 8.4 g of K[0032] 2CO3 in 1,4-dioxane, maintained at reflux condition was treated dropwise with a solution of 3.7 g of 2-chloro-3-methoxycyclohept-1-one in 1,4-dioxane. After 2 h the mixture was cooled to room temperature, followed by extraction with ethyl acetate. The organic solution was washed with water, brine and dried over Na2SO4, filtered and concentrated. The crude product was dissolved in toluene, followed by extraction with 10% aqueous NaOH. The aqueous solution was acidified to pH 5.0 with 10% hydrochloric acid and extracted with ethyl acetate. The organic solution was concentrated, followed by acidification with, ethanol which is saturated by hydrochloric acid, and the solvent was removed in vacuo. The residue was recrystallized from ethyl alcohol-diethyl ether to give 3.1 g of title compound.
    [0033] MS(m/z): 192 (M—HCl)[0033] +, 164,131, 95,67.
    [0034] [0034] 1H-NMR(CD3OD) δ: 0.97 (3H, t, J=6.3Hz), 1.70-1.82 (2H, m), 2.00 (4H, m), 2.68-2.72 (4H, m), 2.98 (2H, t, J=6.3Hz).
    [0035] Effectiveness of the Invention [0035]
    [0036] The novel compounds of this invention, 3-hydoxy-2-halocycloheptenone and 3-alkoxy-2-halocycloheptenone, are key synthetic intermediates of cycloheptanoido derivatives. For example, cycloheptimidazol derivatives can be synthesized by using 3-alkoxy-2-halocycloheptenone easily. The compounds of the present invention can be synthesized easily by a short process, and this invention has the advantage that the compounds can be obtained in practical scale with no use of heavy metals and hazardous reagents which present a risk to environmental sanitation. [0036]
    [0037] This invention relates to novel key intermediates, the cycloheptanoide compounds such as cycloheptimidazole derivatives, and their use for the production method of the cycloheptimidazole derivatives. [0037]
    权利要求:
    Claims (1)
    [1" id="US-20010008944-A1-CLM-00001] 1. A method for preparation of a cycloheptimidazole compound having formula (5),
    wherein: R4 is a lower alkyl group, comprising reacting a compound of formula (1),
    with an alkylamidine hydrochloride.
    类似技术:
    公开号 | 公开日 | 专利标题
    US7750167B2|2010-07-06|Process for the preparation of asenapine and intermediate products used in said process
    GB2045760A|1980-11-05|Process for the preparation of 2,5- bis|-N-| benzamide |
    JP2804558B2|1998-09-30|Method for producing 2-chloro-5-chloromethylpyridine
    JP2001512091A|2001-08-21|Method for producing cyclopropylacetylene
    US6316634B2|2001-11-13|Method for preparing cycloheptimidazoles
    JPH0784413B2|1995-09-13|3- | -1-alkyl-2-oxocyclopentanecarboxylic acid alkyl ester derivative, its production method, bactericide and use as intermediate
    JP2543983B2|1996-10-16|Process for producing 4-disubstituted phenyl-1-tetralones
    US6350915B1|2002-02-26|Process for the synthesis of 1-|-phenyl)ethan-1-one
    HU199798B|1990-03-28|Process for producing 2-substituted-5-methyl-pyridine derivatives
    US4980489A|1990-12-25|2-|-3-hydroxy-1,4-naphthoquinone
    US6489507B1|2002-12-03|Process for the synthesis of 3,5-bis|benzoic acid
    US5225578A|1993-07-06|2-|-3-hydroxy-1,4-naphthoquinone, process for its production and processes for producing 2-|-3-hydroxy-1,4-naphthoquinone and 2-alkyl-3-acyloxy-1,4-naphthoquinone by using it
    JP2586950B2|1997-03-05|Process for producing p- or m-tert-butoxybenzaldehyde
    IE47793B1|1984-06-27|1-hydrocarbylpyrrole derivatives
    JP3976286B2|2007-09-12|Method for producing 2-benzoyl-cyclic 1,3-diketone derivative
    CN107428648B|2021-12-10|Process for the preparation of compounds such as 3-arylbutyraldehyde useful for the synthesis of medetomidine
    JP2801647B2|1998-09-21|Method for producing 6-fluorochromone-2-carboxylic acid derivative
    US6814895B2|2004-11-09|Process for the synthesis of 1-|phenyl)ethan-1-one
    JPH05286882A|1993-11-02|Production of 2,3-difluorophenols
    US4215074A|1980-07-29|Process for preparing cis-bicyclooctylamines
    JPH0841005A|1996-02-13|Production of 4-fluoroalkoxycynnamonitrile compound
    JP2833672B2|1998-12-09|Method for producing β-ketonitrile
    JP2531228B2|1996-09-04|Biphenyl derivative and method for producing the same
    JPH07133270A|1995-05-23|Chroman derivative and its production
    JPH07126260A|1995-05-16|2-alkyl-3-styryloxiranecarboxylic acid ester and its production
    同族专利:
    公开号 | 公开日
    GB2341388B|2003-08-06|
    JP4018816B2|2007-12-05|
    GB2341388A|2000-03-15|
    US6316634B2|2001-11-13|
    US6278027B1|2001-08-21|
    JP2000086569A|2000-03-28|
    DE19942897B4|2006-12-14|
    GB9921224D0|1999-11-10|
    DE19942897A1|2000-03-09|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3084194A||1963-04-02||Preparation of tropones |
    US3320272A||1967-05-16||Process for preparing z-alkoxycyclo-heptimidazole derivatives |
    US2662098A|1951-06-04|1953-12-08|Du Pont|Haloalkyl substituted cycloheptatrien-1-ol-2-one ring compounds and methods for their preparation|
    US4057556A|1976-06-17|1977-11-08|Ayerst, Mckenna & Harrison Ltd.|Troponyl-oxamic acid derivatives|
    JPH0410458B2|1983-09-28|1992-02-25|||
    JPS6257175B2|1985-03-20|1987-11-30|Masatoshi Yamato||
    US4749681A|1986-05-22|1988-06-07|International Flavors & Fragrances Inc.|Polyalkyl-substituted oxocycloheptane derivatives, organoleptic uses thereof and processes for preparing same|
    US5151450A|1990-02-22|1992-09-29|Tokyo Tanabe Company, Limited|Antiulcer substance|
    JP2707390B2|1992-05-22|1998-01-28|壽製薬株式会社|Cycloheptoimidazole derivative, method for producing the same, and drug containing the same|
    ZA945190B|1993-07-30|1995-02-24|Kotobuki Seiyaku Co Ltd|Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds|US7105513B2|2002-08-07|2006-09-12|Sanofi-Avertis Deutschland Gmbh|Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals|
    法律状态:
    2005-06-02| REMI| Maintenance fee reminder mailed|
    2005-08-22| FPAY| Fee payment|Year of fee payment: 4 |
    2005-08-22| SULP| Surcharge for late payment|
    2009-04-15| FPAY| Fee payment|Year of fee payment: 8 |
    2013-06-21| REMI| Maintenance fee reminder mailed|
    2013-11-13| LAPS| Lapse for failure to pay maintenance fees|
    2013-12-09| STCH| Information on status: patent discontinuation|Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
    2013-12-31| FP| Lapsed due to failure to pay maintenance fee|Effective date: 20131113 |
    优先权:
    申请号 | 申请日 | 专利标题
    JP25359598A|JP4018816B2|1998-09-08|1998-09-08|Cycloheptenone derivative and method for producing the same, and method for producing cycloheptimidazole derivative using the same|
    JP10-253595||1998-09-08||
    JP253595/98||1998-09-08||
    US09/391,385|US6278027B1|1998-09-08|1999-09-08|3-Substituted-2-halocycloheptenone compounds and a method for manufacturing same|
    US09/805,516|US6316634B2|1998-09-08|2001-03-14|Method for preparing cycloheptimidazoles|US09/805,516| US6316634B2|1998-09-08|2001-03-14|Method for preparing cycloheptimidazoles|
    [返回顶部]